Fundraising FoxFlagship Pioneering — 2015 Investments
4 investments dated 2015 · listed companies and verified rows first · show all
Denali Therapeutics develops therapeutics for neurodegenerative diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Marc Tessier-Lavigne(Founder)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)inAlexander Schuth(Founder)
Co-investorsARCH Venture PartnersEcoR1 CapitalF-Prime CapitalForesite CapitalGV (Google Ventures)Flagship Ventures
BG Medicine develops and commercializes cardiovascular diagnostic tests to assess heart failure risk and predict cardiovascular events.
BiotechDigital HealthHealthtechMedical DevicesWaltham, US
Stephen Hall(Executive Officer)inPaul Sohmer(Executive Officer, Director)Aram Adourian(Executive Officer)Harry Wilcox(Director)Paul R. Sohmer, M.D.(President and CEO)
Board seatNoubar Afeyan· per SEC Form D · $2.5M raise · filed May 2015
Cambridge, MA clinical-stage biotech developing engineered exosome therapeutics; IPO'd on NASDAQ in 2020, later restructured.
BiotechSeattle, US
Doug Williams(Executive Officer, Director)in
BoardSteven Gillis(Director)Eric Lander(Director)
Board seatNoubar Afeyan· per SEC Form D
Co-investorsARCH Venture PartnersEcoR1 CapitalAlexandriaFidelity InvestmentsQatar Investment Authority
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.